Abbott Laboratories (NYSE:ABT) Upgraded by Atlantic Securities to Overweight

Abbott Laboratories} stock has undergone multiple analysts rating changes in the recent past.  Abbott Laboratories Upgraded by Atlantic Securities on 10/27/2021. In a note to investors, the firm issued a new rating of Overweight. The analysts previously had rating of Neutral.

View More Abbott Laboratories (NYSE:ABT) Upgraded by Atlantic Securities to Overweight

Abbott Laboratories (NYSE:ABT) Target Raised by Raymond James to $134.00

StockMarketDaily.co reports: Abbott Laboratories stock has undergone multiple analysts rating changes in the recent past.  Abbott Laboratories stock Target Raised by   Raymond James on 10/21/2021. In a note to investors, the firm issued a new target price of $134.00. The analysts previously had $128.00 target price.

View More Abbott Laboratories (NYSE:ABT) Target Raised by Raymond James to $134.00